CGEM
USDCullinan Therapeutics Inc. Common Stock
$7.400-0.400 (-5.128%)
Echtzeitkurs
Healthcare
Biotechnologie
Vereinigte Staaten
Kursdiagramm
Loading Chart...
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$7.800
Hoch
$7.800
Tief
$7.360
Volumen
0.61M
Unternehmensfundamentaldaten
Marktkapitalisierung
437.2M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.89M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Tief $5.68Aktuell $7.400Hoch $17.503
Ähnliche Nachrichten
GlobeNewswire
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
Mehr anzeigen
GlobeNewswire
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
Mehr anzeigen
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.